+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The bile acid synthetic gene 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis

The bile acid synthetic gene 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis

Journal of Clinical Investigation 106(9): 1175-1184

We used expression cloning to isolate cDNAs encoding a microsomal 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase (C(27) 3beta-HSD) that is expressed predominantly in the liver. The predicted product shares 34% sequence identity with the C(19) and C(21) 3beta-HSD enzymes, which participate in steroid hormone metabolism. When transfected into cultured cells, the cloned C(27) 3beta-HSD cDNA encodes an enzyme that is active against four 7alpha-hydroxylated sterols, indicating that a single C(27) 3beta-HSD enzyme can participate in all known pathways of bile acid synthesis. The expressed enzyme did not metabolize several different C(19/21) steroids as substrates. The levels of hepatic C(27) 3beta-HSD mRNA in the mouse are not sexually dimorphic and do not change in response to dietary cholesterol or to changes in bile acid pool size. The corresponding human gene on chromosome 16p11.2-12 contains six exons and spans 3 kb of DNA, and we identified a 2-bp deletion in the C27 3beta-HSD gene of a patient with neonatal progressive intrahepatic cholestasis. This mutation eliminates the activity of the enzyme in transfected cells. These findings establish the central role of C(27) 3beta-HSD in the biosynthesis of bile acids and provide molecular tools for the diagnosis of a third type of neonatal progressive intrahepatic cholestasis associated with impaired bile acid synthesis.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 011479495

Download citation: RISBibTeXText

PMID: 11067870

Related references

Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease. Journal of Clinical Endocrinology and Metabolism 88(4): 1833-1841, 2003

Titration of bile acid supplements in 3beta-hydroxy-Delta 5-C27-steroid dehydrogenase/isomerase deficiency. Journal of Pediatric Gastroenterology and Nutrition 50(6): 655-660, 2010

Comparisons of the enz dehydroiso andro sterone delta 5 3beta hydroxy steroid dehydrogenase and the enz delta 5 pregnenolone delta 5 3beta hydroxy steroid dehydrogenase activities of ovaries of control hemi ovariectomized gonadotrophin hormone treated and androgen metab sterilized young rats. Endocrinology: 626-628, 1968

New potent inhibitors of 3beta-hydroxy-delta 5-steroid oxidoreductase with short duration of action. Endocrinology 95(1): 238-246, 1974

Variable clinical spectrum of the most common inborn error of bile acid metabolism--3beta-hydroxy-Delta 5-C27-steroid dehydrogenase deficiency. Journal of Pediatric Gastroenterology and Nutrition 50(1): 61-66, 2010

A new cause of progressive intrahepatic cholestasis: 3 beta-hydroxy-C27-steroid dehydrogenase/isomerase deficiency. Journal of Pediatrics 125(3): 379-384, 1994

A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nature Genetics 20(3): 233-238, 1998

Enterocyte inclusions are associated with diarrhea in both genetically documented progressive familial intrahepatic cholestasis, type 1, and intrahepatic cholestasis characterized by coarsely granular Byler bile. Hepatology 32(4 Pt 2): 211A, 2000

Bile acid pool dynamics in progressive familial intrahepatic cholestasis with partial external bile diversion. Journal of Pediatric Gastroenterology and Nutrition 60(3): 368-374, 2015

Tandem mass spectrometric determination of atypical 3β-hydroxy-Δ5-bile acids in patients with 3β-hydroxy-Δ5-C27-steroid oxidoreductase deficiency: application to diagnosis and monitoring of bile acid therapeutic response. Clinical Chemistry 61(7): 955-963, 2015

The SPGP gene, encoding the canalicular bile acid transporting protein SPGP/cBST, is not expressed in a subgroup of patients with progressive familial intrahepatic cholestasis. Journal of Hepatology 28(Suppl. 1): 42, 1998

Progressive familial intrahepatic cholestasis and inborn errors of bile acid synthesis. Clinics and Research in Hepatology and Gastroenterology 36(3): 271-274, 2012

Bile acid profiles in siblings with progressive intrahepatic cholestasis: absence of biliary chenodeoxycholate. Journal of Pediatric Gastroenterology and Nutrition 4(1): 32-37, 1985

Interest of urine bile acid profile in the diagnosis of progressive intrahepatic neonatal cholestasis. Clinical Chemistry & Laboratory Medicine 37(SPEC Suppl. ): S418, 1999

Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis. European Journal of Pediatrics 153(6): 424-428, 1994